GrittGene Therapeutics is a cutting-edge biotech company based in Glendale, CA, dedicated to finding a cure for Myotonic Dystrophy through the use of advanced technologies such as CRISPR and Artificial Intelligence.
With a multidisciplinary approach and a global network of laboratories, GrittGene Therapeutics aims to provide innovative solutions for the diagnosis and treatment of this multisystemic disorder, prioritizing the well-being of individuals affected by Myotonic Dystrophy.
Generated from the website